TerminatedPhase 1NCT01012362

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Studying Sarcoma of cervix uteri

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Masonic Cancer Center, University of Minnesota
Principal Investigator
Arkaduisz Z Dudek, MD
Masonic Cancer Center, University of Minnesota
Intervention
Pazopanib(drug)
Enrollment
31 enrolled
Eligibility
18 years · All sexes
Timeline
20092013

Study locations (1)

Collaborators

GlaxoSmithKline

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01012362 on ClinicalTrials.gov

Other trials for Sarcoma of cervix uteri

Additional recruiting or active studies for the same condition.

See all trials for Sarcoma of cervix uteri

← Back to all trials